565 related articles for article (PubMed ID: 30250825)
1. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis.
Fabregat I; Caballero-Díaz D
Front Oncol; 2018; 8():357. PubMed ID: 30250825
[TBL] [Abstract][Full Text] [Related]
2. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
3. TGF-β signalling and liver disease.
Fabregat I; Moreno-Càceres J; Sánchez A; Dooley S; Dewidar B; Giannelli G; Ten Dijke P;
FEBS J; 2016 Jun; 283(12):2219-32. PubMed ID: 26807763
[TBL] [Abstract][Full Text] [Related]
4. Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions.
Yoshida K; Murata M; Yamaguchi T; Matsuzaki K; Okazaki K
J Clin Med; 2016 Jan; 5(1):. PubMed ID: 26771649
[TBL] [Abstract][Full Text] [Related]
5. The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells.
Caja L; Bertran E; Campbell J; Fausto N; Fabregat I
J Cell Physiol; 2011 May; 226(5):1214-23. PubMed ID: 20945437
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
7. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes.
Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J
J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572
[TBL] [Abstract][Full Text] [Related]
8. Cross-Talk Between TGF-β and NADPH Oxidases During Liver Fibrosis and Hepatocarcinogenesis.
Crosas-Molist E; Bertran E; Fabregat I
Curr Pharm Des; 2015; 21(41):5964-76. PubMed ID: 26510436
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
Shen M; Liu X; Zhang H; Guo SW
Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
[TBL] [Abstract][Full Text] [Related]
10. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis.
Caja L; Ortiz C; Bertran E; Murillo MM; Miró-Obradors MJ; Palacios E; Fabregat I
Cell Signal; 2007 Apr; 19(4):683-94. PubMed ID: 17055226
[TBL] [Abstract][Full Text] [Related]
11. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
12. Chronic liver injury, TGF-beta, and cancer.
Bissell DM
Exp Mol Med; 2001 Dec; 33(4):179-90. PubMed ID: 11795478
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling.
Ding ZY; Jin GN; Liang HF; Wang W; Chen WX; Datta PK; Zhang MZ; Zhang B; Chen XP
Cell Signal; 2013 Oct; 25(10):1981-92. PubMed ID: 23727026
[TBL] [Abstract][Full Text] [Related]
14. Anti-TGF-beta strategies for the treatment of chronic liver disease.
Breitkopf K; Haas S; Wiercinska E; Singer MV; Dooley S
Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):121S-131S. PubMed ID: 16344596
[TBL] [Abstract][Full Text] [Related]
15. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
16. Regulation of TGF-β1-Induced Pro-Apoptotic Signaling by Growth Factor Receptors and Extracellular Matrix Receptor Integrins in the Liver.
Ozaki I; Hamajima H; Matsuhashi S; Mizuta T
Front Physiol; 2011; 2():78. PubMed ID: 22028694
[TBL] [Abstract][Full Text] [Related]
17. Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries.
Yoshida K; Matsuzaki K
Front Physiol; 2012; 3():53. PubMed ID: 22457652
[TBL] [Abstract][Full Text] [Related]
18. The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
Gonzalez-Sanchez E; Vaquero J; Férnandez-Barrena MG; Lasarte JJ; Avila MA; Sarobe P; Reig M; Calvo M; Fabregat I
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209646
[TBL] [Abstract][Full Text] [Related]
19. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis.
Gressner AM
Kidney Int Suppl; 1996 May; 54():S39-45. PubMed ID: 8731193
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
